Jean-Marc Bellemin
Director of Finance/CFO at IOVANCE BIOTHERAPEUTICS, INC.
Net worth: 675 967 $ as of 2024-04-29
Jean-Marc Bellemin active positions
| Companies | Position | Start | End |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Comptroller/Controller/Auditor | 2021-03-10 | - |
| Director of Finance/CFO | 2020-12-13 | - | |
| Treasurer | 2020-12-13 | - |
Career history of Jean-Marc Bellemin
Former positions of Jean-Marc Bellemin
| Companies | Position | Start | End |
|---|---|---|---|
| GRITSTONE BIO, INC. | Director of Finance/CFO | 2017-12-31 | 2020-12-10 |
Actelion Pharmaceuticals US, Inc.
 Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Corporate Officer/Principal | 2007-12-31 | 2017-11-30 |
Training of Jean-Marc Bellemin
| Université Paris Dauphine-PSL | Undergraduate Degree |
| Université Paris II Panthéon Assas | Graduate Degree |
| ESSEC Business School | Masters Business Admin |
Statistics
International
| United States | 4 |
| France | 4 |
Operational
| Director of Finance/CFO | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| GRITSTONE BIO, INC. | Health Technology |
| IOVANCE BIOTHERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Health Technology |
- Stock Market
- Insiders
- Jean-Marc Bellemin
- Experience
